MEDICONED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICONED
Largest movements
- Receivables within one year -€14,795
down €14,795 (-37.8%), from €39,109 to €24,314
- Cash +€2,636
up €2,636 (+5.5%), from €48,182 to €50,818
mainly Receivables within one year (+€14,795) and Net result for the year (+€6,567)
- Tangible fixed assets -€2,070
down €2,070 (-12.9%), from €16,070 to €13,999
of which Land and buildings: -€1,500
- Advances received -€21,079
no longer reported in 2025 (was €21,079)
- Trade debts +€5,060
up €5,060 (+44.4%), from €11,392 to €16,452
- Tax, wage and social debts +€4,969
up €4,969 (+24.7%), from €20,138 to €25,107
- Reserves -€2,433
down €2,433 (-5.2%), from €46,799 to €44,367
of which Distributable reserves: -€2,433
- Gross operating margin +€21,732
up €21,732, from -€5,835 to €15,897
- Taxes +€2,533
up €2,533 (+779.5%), from €325 to €2,858
- Financial charges +€2,034
up €2,034 (+337.4%), from €603 to €2,636
- Other operating charges -€471
down €471 (-21.1%), from €2,236 to €1,765
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €106,594 | €92,126 | -€14,469 | -13.6% |
| Fixed assets | 21/28 | €19,064 | €16,994 | -€2,070 | -10.9% |
| Tangible fixed assets | 22/27 | €16,070 | €13,999 | -€2,070 | -12.9% |
| Land and buildings | 22 | €15,003 | €13,503 | -€1,500 | -10.0% |
| Furniture and vehicles | 24 | €275 | €39 | -€237 | -85.9% |
| Other tangible fixed assets | 26 | €791 | €457 | -€334 | -42.2% |
| Financial fixed assets | 28 | €2,995 | €2,995 | = | 0.0% |
| Current assets | 29/58 | €87,530 | €75,132 | -€12,398 | -14.2% |
| Amounts receivable within one year | 40/41 | €39,109 | €24,314 | -€14,795 | -37.8% |
| Trade receivables | 40 | €39,109 | €24,314 | -€14,795 | -37.8% |
| Cash at bank and in hand | 54/58 | €48,182 | €50,818 | +€2,636 | +5.5% |
| Deferred charges and accrued income | 490/1 | €239 | - | -€239 | |
| Total equity and liabilities | 10/49 | €106,594 | €92,126 | -€14,469 | -13.6% |
| Equity | 10/15 | €52,999 | €50,567 | -€2,433 | -4.6% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €46,799 | €44,367 | -€2,433 | -5.2% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €44,939 | €42,507 | -€2,433 | -5.4% |
| Amounts payable | 17/49 | €53,595 | €41,559 | -€12,036 | -22.5% |
| Amounts payable within one year | 42/48 | €53,595 | €41,559 | -€12,036 | -22.5% |
| Trade debts | 44 | €11,392 | €16,452 | +€5,060 | +44.4% |
| Suppliers | 440/4 | €11,392 | €16,452 | +€5,060 | +44.4% |
| Advances received on contracts in progress | 46 | €21,079 | - | -€21,079 | |
| Taxes, remuneration and social security | 45 | €20,138 | €25,107 | +€4,969 | +24.7% |
| Taxes | 450/3 | €20,138 | €25,107 | +€4,969 | +24.7% |
| Other amounts payable | 47/48 | €986 | - | -€986 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,070 | €2,070 | = | 0.0% |
| Other operating charges | 640/8 | €2,236 | €1,765 | -€471 | -21.1% |
| Gross operating margin | 9900 | -€5,835 | €15,897 | +€21,732 | |
| Operating profit (loss) | 9901 | -€10,142 | €12,062 | +€22,204 | |
| Financial charges | 65/66B | €603 | €2,636 | +€2,034 | +337.4% |
| Recurring financial charges | 65 | €603 | €2,636 | +€2,034 | +337.4% |
| Profit (loss) for the period before taxes | 9903 | -€10,744 | €9,426 | +€20,170 | |
| Income taxes | 67/77 | €325 | €2,858 | +€2,533 | +779.5% |
| Profit (loss) for the period | 9904 | -€11,069 | €6,567 | +€17,637 | |
| Profit (loss) for the period to be appropriated | 9905 | -€11,069 | €6,567 | +€17,637 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.